Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 6 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Ligand Pharmaceuticals Inc have a median target of 140.00, with a high estimate of 157.00 and a low estimate of 1.63. The median estimate represents a 20.12% increase from the last price of 116.55.
High | 34.7% | 157.00 |
Med | 20.1% | 140.00 |
Low | -98.6% | 1.63 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | +17.59% |
Average growth rate | +22.52% |
More ▼
Revenue history & estimates in USD
Average growth rate | +13.64% |
Average growth rate | +10.34% |
More ▼